논문KCI 등재
What’s new in molecular genetic pathology 2022: immune checkpoint inhibitor biomarkers and select solid tumors
대한병리학회|2022.03|Journal of Pathology and Translational Medicine|제56권 제2호|pp. 113-114|DOI 10.4132/jptm.2022.01.25
0
조회
0
다운로드
0
인용
0
참고문헌
주제분류병리학
초록
Predictive biomarker testing plays a critical role in targeted immuno-oncology, including the use of immune checkpoint inhibitors (ICI) for various solid tumors. Molecular advancements in cancers of the breast, kidney and brain have continued to propel tumor classification and precision therapy.
Abstract
Predictive biomarker testing plays a critical role in targeted immuno-oncology, including the use of immune checkpoint inhibitors (ICI) for various solid tumors. Molecular advancements in cancers of the breast, kidney and brain have continued to propel tumor classification and precision therapy.
참고문헌 (4)
- Bruford EA, "HUGO Gene Nomenclature Committee(HGNC)recommendations for the designation of gene fusions", Leukemia, 35, pp.3040~3043 (2021)
- Shahbandi A, "TP53 mutations and outcomes in breast cancer : reading beyond the headlines", Trends Cancer, 6, pp.98~110 (2020)
- Henske EP, "Renal Cell Carcinoma in tuberous sclerosis complex", Genes(Basel), 12, pp.1585~ (2021)
- Price G, "Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma", EBioMedicine, 69, pp.103453~ (2021)
관련 논문AI추천
What’s new in molecular genetic pathology 2021: solid tumors and NGS panel selectionGuoli Chen, Patricia C. Tsang대한병리학회 · Journal of Pathology and Translational Medicine2021 · 제55권 제6호What’s new in breast pathology 2022: WHO 5th edition and biomarker updatesGary Tozbikian, Julie M. Jorns, Kristen Muller대한병리학회 · Journal of Pathology and Translational Medicine2022 · 제56권 제3호DNA-protein biomarkers for immunotherapy in the era of precision oncology강소영, 김경미, 김빛내리대한병리학회 · Journal of Pathology and Translational Medicine2021 · 제55권 제1호What’s new in bone and soft tissue pathology 2023: guidelines for molecular testingFarres Obeidin대한병리학회 · Journal of Pathology and Translational Medicine2023 · 제57권 제3호What’s new in kidney tumor pathology 2022: who 5th edition updatesMaria Tretiakova대한병리학회 · Journal of Pathology and Translational Medicine2022 · 제56권 제6호Molecular Testing of Lung Cancers김완섭, 김태정, 노미숙, 심효섭, 이건국, 장선희, 장세진, 정진행, 최윤라, 하승연, 김루시아대한병리학회 · Journal of Pathology and Translational Medicine2017 · 제51권 제3호
이 간행물의 다른 논문 (8건)
Extremely well-differentiated adenocarcinoma of the stomach: diagnostic pitfalls in endoscopic biopsy안지용, 이인섭, 이종원, 김지훈, 박영수pp. 63-72Fatty acid synthetase expression in triple-negative breast cancer박경식, 김완섭, 한혜승, 김욱연, 유영범, 박진희, 이승은, 임소덕pp. 73-80Blocking Toll-like receptor 9 attenuates bleomycin-induced pulmonary injurySaid M. Elshafae, Badr Alzahrani, Mohamed M. S. Gaballa, Ahmed A. Tantawy, Maha A. Moussa, Salma A. Shoulahpp. 81-91An unusual case of microsatellite instability–high/deficient mismatch repair (MSI-H/dMMR) diffuse large B-cell lymphoma revealed by targeted gene sequencing김세희, 전윤경, 고지원, 윤홍석, 배정모, 한보경pp. 92-96Colorectal adenocarcinoma with enteroblastic differentiation: diagnostic challenges of a rare case encountered in clinical practiceEvi Abada, Rafic Beydoun, Anthony Lebbos, Othuke Abada, Ifeoma C. Anayapp. 97-102